Clinical Trials · NCT00489918
Dose Ranging Study - Macroflux Parathyroid Hormone (PTH) in Postmenopausal Women With Osteoporosis
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Zosano Pharma Corporation
- Enrollment
- 165
- Start date
- Jun 2007
- Locations
- See registry
- Primary endpoint
- Percent Change in Lumbar Spine Bone Mineral Density (BMD): Baseline to Week 24